Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Morgan Stanley's stake in Syndax Pharmaceuticals, Inc. fell to 2.40% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 7, 2025
Morgan Stanley's stake in Syndax Pharmaceuticals, Inc. fell to 2.40%, 2,040,013 shares, as a passive investor on Mar 31, 2025. Filed May 7, 2025 (Schedule 13G/A).
- Stake
- 2.40%
- Shares
- 2,040,013
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 2.40% | 2,040,013 |
| Morgan Stanley & Co. LLC | 0.20% | 213,174 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Morgan Stanley
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 5, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026